Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(30 sites)
United States
Applied Research Center of Arkansas, Little Rock, Arkansas Levenson Eye Associates, Jacksonville, Florida Ilumina Medical Research, Kissimmee, Florida Sarasota Retina Institute, Sarasota, Florida Vision Medical Research, Inc., Orland Park, Illinois